Sweeteners · Metabolic & Cardiometabolic
acesulfame-K does not raise blood glucose
Strong support Sweeteners 🔬 Includes disconfirming
Part of: • acesulfame-K
RefutedContestedStrong support
consensus score 0.81
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
17 support 3 contradict 0 tested null 3 mixed · 23 sources, 20 independent groups
What the evidence shows
Acesulfame-K is glycemically inert: it isn't metabolized for energy and RCTs plus a network meta-analysis of non-nutritive-sweetened beverages show no meaningful acute rise in glucose or insulin (blends containing Ace-K actually blunt the insulin response versus sugar). Its debated effects are on the microbiome/appetite, not on acute blood sugar.
The evidence (23)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Teysseire et al. 2024 · Nutrients | observational | supports | low | Narrative review: ace-K glycemically inert (not metabolized for energy). |
| Lin PY et al 2026 · study_type: animal | animal | contradicts | moderate | Chronic high-fat-diet mice given Ace-K (2 mg/mL, 12 weeks) developed impaired glucose tolerance and hepatic lipid accumulation via PLCβ activation in sweet-taste-receptor signaling, dependent on PPARα. |
| Lück A et al 2026 · study_type: meta-analysis | meta-analysis | mixed | low | Systematic review/meta-analysis (22 studies) of artificial sweeteners in diabetics found higher insulin (g=0.50) and HbA1c (g=0.30) in common-effects models, but associations were not significant in random-effects models with substantial he |
| Čad EM et al 2026 · study_type: observational | observational | supports | low | Narrative review synthesizing SWEET/SWITCH/Sweet Tooth European consortia RCTs: NNS consumption and sweet-taste exposure showed no adverse changes in glucoregulatory/endocrine biomarkers, cardiometabolic risk factors, or body weight. |
| Wolnerhanssen et al. 2020 · Crit Rev Food Sci Nutr | observational | supports | moderate | Metabolic review: ace-K no meaningful glycemic effect. |
| Nichol et al. 2018 · Eur J Clin Nutr | meta-analysis | supports | moderate | MA of NNS RCTs: no significant acute glycemic impact (incl. ace-K). |
| Rose BD et al 2024 · study_type: animal | animal | mixed | moderate | Mice given combined sucralose+acesulfame-K (2 weeks) showed 31% increased jejunal glucose absorption (3-OMG marker) independent of gut microbiota, but overall OGTT glycemic responses were NOT disrupted by NNS supplementation alone. |
| Almiron-Roig et al. 2023 · Appetite | RCT | supports | moderate | SWEET beverages RCT: sucralose-acesulfame-K blend reduced 2-h insulin iAUC vs sucrose (no glucose rise). |
| Kossiva L et al 2024 · study_type: observational | observational | contradicts | low | Narrative review states studies have associated artificial sweeteners' consumption with development of insulin resistance and NAFLD, among other effects, discussing chronic-use pros/cons generically. |
| Ahmad et al. 2019 · Curr Opin Clin Nutr Metab Care | observational | supports | low | Review of NNS RCTs: no adverse effect on glycemic control. |
| Pang MD et al 2026 · International Journal of Obesity | RCT | supports | low | SWEET substudy RCT (n=83, 10-month weight-maintenance): sweeteners/sweetness-enhancers (S&SE) group showed no group differences in whole-body insulin sensitivity (oral glucose tolerance test) vs. sugar group, though some adipose lipolytic g |
| Kwan MG et al 2025 · study_type: observational | observational | supports | low | Prospective cohort (n=365 pregnant women): non-nutritive sweetened beverage (NNSB) intake was not associated with fasting glucose or fasting insulin in 2nd trimester, adjusted for covariates. |
| Iizuka 2022 · Nutrients | observational | mixed | low | Review: human meta-analyses find artificial sweeteners incl. Ace-K have no effect on glycemic control. |
| Zhang 2023 · Nutrients | meta-analysis | supports | high | SR + network MA of non-nutritive-sweetened beverages: no meaningful postprandial glycemic/endocrine rise vs water under real-world conditions. |
| Begum RF et al 2025 · study_type: observational | observational | supports | low | Narrative review states artificial sweeteners (aspartame, sucralose, stevia named; Ace-K implied in class) have minimal impact on blood glucose and do not cause hyperglycemia, useful for diabetes glycemic control. |
| Orku 2023 · Nutrition | RCT | supports | moderate | RCT: regular low/no-calorie sweeteners did not impair glucose tolerance in healthy adults. |
| McGlynn 2022 · JAMA Netw Open | meta-analysis | supports | moderate | RCT: NNS beverage vs sugar produced no adverse glycemic response. |
| Ahmad et al. 2020 · Nutr Rev | observational | supports | low | Review of NNS on glucose metabolism/gut hormones: acute glycemic impact negligible. |
| Kim S et al 2025 · study_type: RCT | observational | supports | low | Crossover CGM study (n=66): 'zero cola' (ASB) alone or with a muffin had minimal overall glycemic impact similar to muffin alone, but 17/61 participants showed higher glycemic response in the mixed-meal condition (individual variability). |
| Flad E et al 2025 · study_type: RCT | RCT | supports | moderate | Randomized double-blind crossover trial (n=20): oral ace-K preload (0.1675 g) led to lower plasma glucose and insulin than sucrose preload, with ace-K not differing from water/xylitol on glucose. |
| Beigrezaei S et al 2026 · European Journal of Nutrition | observational | contradicts | low | HELIUS prospective cohort (n=2612): higher non-sugar-sweetened beverage (NSSB, class including ace-K) intake was associated with increased incident type-2-diabetes risk (IRR 2.26), and substituting SSB with NSSB raised T2D risk in younger p |
| Odegaard AO et al 2026 · study_type: RCT | RCT | supports | moderate | RCT (SODAS, n=179, T2D patients): substituting water for habitual artificially sweetened beverages (ASBs, commonly containing ace-K) over 24 weeks did NOT improve HbA1c or glycemic measures — the ASB arm's HbA1c was actually slightly lower, |
| Galicia-Ayala C et al 2026 · study_type: RCT | RCT | supports | moderate | Randomized crossover trial (n=20): aspartame/acesulfame-K beverage (AAK) showed no significant differences in glucose, insulin, glucagon, GIP, PP, leptin, or ghrelin vs. carbonated water control over 120 min. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.